Status report from the Scientific Panel on Antibiotic Use in Dermatology of the American Acne and Rosacea Society - Part 3: Current perspectives on skin and soft tissue infections with emphasis on methicillin-resistant Staphylococcus aureus, commonly encountered scenarios when antibiotic use may not be needed, and concluding remarks on rational use of antibiotics in dermatology

James Q. Del Rosso, Ted Rosen, Diane Thiboutot, Guy F. Webster, Richard L. Gallo, James J. Leyden, Clay Walker, George Zhanel, Lawrence Eichenfield

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

In this third article of the three-part series, management of skin and soft tissue infections is reviewed with emphasis on new information on methicillin-resistant Staphylococcus aureus. Due to changes in the evolution of methicillin-resistant Staphylococcus aureus clones, previous distinctions between healthcare-acquired methicillin-resistant Staphylococcus aureus and community-acquired methicillin-resistant Staphylococcus aureus are currently much less clinically relevant. Many nosocomial cases of methicillin-resistant Staphylococcus aureus infection are now caused by community-acquired methicillin-resistant Staphylococcus aureus, with changing patterns of antibiotic susceptibility and resistance. Also reviewed are clinical scenarios where antibiotics may not be needed and suggestions for optimal use of antibiotic therapy for dermatologic conditions, including recommendations on perioperative antibiotic use.

Original languageEnglish (US)
Pages (from-to)17-24
Number of pages8
JournalJournal of Clinical and Aesthetic Dermatology
Volume9
Issue number6
StatePublished - Jun 1 2016

Fingerprint

Rosacea
Soft Tissue Infections
Methicillin-Resistant Staphylococcus aureus
Dermatology
Anti-Bacterial Agents
Skin
Microbial Drug Resistance
Clone Cells
Delivery of Health Care
Infection

All Science Journal Classification (ASJC) codes

  • Dermatology

Cite this

@article{9783a2ccd8674a44a39e219419a04301,
title = "Status report from the Scientific Panel on Antibiotic Use in Dermatology of the American Acne and Rosacea Society - Part 3: Current perspectives on skin and soft tissue infections with emphasis on methicillin-resistant Staphylococcus aureus, commonly encountered scenarios when antibiotic use may not be needed, and concluding remarks on rational use of antibiotics in dermatology",
abstract = "In this third article of the three-part series, management of skin and soft tissue infections is reviewed with emphasis on new information on methicillin-resistant Staphylococcus aureus. Due to changes in the evolution of methicillin-resistant Staphylococcus aureus clones, previous distinctions between healthcare-acquired methicillin-resistant Staphylococcus aureus and community-acquired methicillin-resistant Staphylococcus aureus are currently much less clinically relevant. Many nosocomial cases of methicillin-resistant Staphylococcus aureus infection are now caused by community-acquired methicillin-resistant Staphylococcus aureus, with changing patterns of antibiotic susceptibility and resistance. Also reviewed are clinical scenarios where antibiotics may not be needed and suggestions for optimal use of antibiotic therapy for dermatologic conditions, including recommendations on perioperative antibiotic use.",
author = "{Del Rosso}, {James Q.} and Ted Rosen and Diane Thiboutot and Webster, {Guy F.} and Gallo, {Richard L.} and Leyden, {James J.} and Clay Walker and George Zhanel and Lawrence Eichenfield",
year = "2016",
month = "6",
day = "1",
language = "English (US)",
volume = "9",
pages = "17--24",
journal = "Journal of Clinical and Aesthetic Dermatology",
issn = "1941-2789",
publisher = "Matrix Medical Communications",
number = "6",

}

TY - JOUR

T1 - Status report from the Scientific Panel on Antibiotic Use in Dermatology of the American Acne and Rosacea Society - Part 3

T2 - Current perspectives on skin and soft tissue infections with emphasis on methicillin-resistant Staphylococcus aureus, commonly encountered scenarios when antibiotic use may not be needed, and concluding remarks on rational use of antibiotics in dermatology

AU - Del Rosso, James Q.

AU - Rosen, Ted

AU - Thiboutot, Diane

AU - Webster, Guy F.

AU - Gallo, Richard L.

AU - Leyden, James J.

AU - Walker, Clay

AU - Zhanel, George

AU - Eichenfield, Lawrence

PY - 2016/6/1

Y1 - 2016/6/1

N2 - In this third article of the three-part series, management of skin and soft tissue infections is reviewed with emphasis on new information on methicillin-resistant Staphylococcus aureus. Due to changes in the evolution of methicillin-resistant Staphylococcus aureus clones, previous distinctions between healthcare-acquired methicillin-resistant Staphylococcus aureus and community-acquired methicillin-resistant Staphylococcus aureus are currently much less clinically relevant. Many nosocomial cases of methicillin-resistant Staphylococcus aureus infection are now caused by community-acquired methicillin-resistant Staphylococcus aureus, with changing patterns of antibiotic susceptibility and resistance. Also reviewed are clinical scenarios where antibiotics may not be needed and suggestions for optimal use of antibiotic therapy for dermatologic conditions, including recommendations on perioperative antibiotic use.

AB - In this third article of the three-part series, management of skin and soft tissue infections is reviewed with emphasis on new information on methicillin-resistant Staphylococcus aureus. Due to changes in the evolution of methicillin-resistant Staphylococcus aureus clones, previous distinctions between healthcare-acquired methicillin-resistant Staphylococcus aureus and community-acquired methicillin-resistant Staphylococcus aureus are currently much less clinically relevant. Many nosocomial cases of methicillin-resistant Staphylococcus aureus infection are now caused by community-acquired methicillin-resistant Staphylococcus aureus, with changing patterns of antibiotic susceptibility and resistance. Also reviewed are clinical scenarios where antibiotics may not be needed and suggestions for optimal use of antibiotic therapy for dermatologic conditions, including recommendations on perioperative antibiotic use.

UR - http://www.scopus.com/inward/record.url?scp=84975865497&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84975865497&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:84975865497

VL - 9

SP - 17

EP - 24

JO - Journal of Clinical and Aesthetic Dermatology

JF - Journal of Clinical and Aesthetic Dermatology

SN - 1941-2789

IS - 6

ER -